Use of istradefylline (kw-6002) for the treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/522 (2006.01) A61P 25/14 (2006.01)

Patent

CA 2511779

The present invention provides a method of treating behavioral disorders such as attention deficit hyperactivity disorder, comprising administering an effective amount of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine or a pharmaceutically acceptable salt thereof to a patient in need thereof and the like.

L'invention porte sur une méthode de traitement de troubles du comportement tels que le déficit d'attention avec hyperactivité consistant à administrer une dose efficace de (E)-8-(3,4-diméthoxystyryl)-1,3-diéthyl-7-méthylxanthine ou l'un de ses sels pharmacocompatibles à un patient le nécessitant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of istradefylline (kw-6002) for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of istradefylline (kw-6002) for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of istradefylline (kw-6002) for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1629135

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.